Skip to main content
SpringerLink
Log in

Safety of seven COVID-19 vaccine booster doses

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Munro APS, et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial Lancet : 2 Dec 2021. Available from: URL: https://doi.org/10.1016/S0140-6736(21)02717-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Safety of seven COVID-19 vaccine booster doses. Reactions Weekly 1885, 11 (2021). https://doi.org/10.1007/s40278-021-06770-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-06770-9

Search

Navigation